• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 CONCERTO NYLON; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 CONCERTO NYLON; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Model Number NV-8-30-HELIX
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Erythema (1840); Hypersensitivity/Allergic reaction (1907); Pain (1994); Paresthesia (4421); Swelling/ Edema (4577)
Date of Event 01/01/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The event was noted to be reported by the unidentified male patient.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Medtronic received a report that the patient began experiencing symptoms two weeks after being implanted with concerto coils.They initially experienced needles and pins in their feet and severe pains, swelling and redness in different areas of their body.Their quality of life was severely impacted.They underwent multiple different test to identify reasons for this problem and after 2 years they said the coils might be causing an allergic reaction. there were no malfunctions with the device, and the devices were prepared according to the instructions for use (ifu).The patient was undergoing treatment for varicocele.Additional information received reported allergy to the concerto coils was only considered after 2 years of testing.The patient underwent several scans, arthritic treatments, and allergy tests.Additional information received reported the patient saw several doctor and was hospitalized to address the pain related to the event.The events were not considered life-threatening but were noted to be detrimental to the patient's quality of life.The patient continues to have symptoms.Refer to manufacturer report 2029214-2021-01043 for details pertaining to the related reportable event.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONCERTO NYLON
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
MDR Report Key12348845
Report Number2029214-2021-01045
Device Sequence Number19910718
Product Code KRD
UDI-Device Identifier00847536013704
UDI-Public00847536013704
Combination Product (Y/N)N
Initial Reporter CountrySF
PMA/510(K) Number
K090046
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/07/2020
Device Model NumberNV-8-30-HELIX
Device Catalogue NumberNV-8-30-HELIX
Device Lot NumberA553435
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/02/2021
Supplement Date Received by Manufacturer09/23/2021
Initial Report FDA Received Date08/20/2021
Supplement Report FDA Received Date10/07/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Disability;
Patient Age30 YR
-
-